325 Women Tested Whether the Pill Kills Gains

325 women. Eight studies. Fifty-four separate measurements of whether the birth control pill changes how much muscle, strength, or power you build from lifting weights.

The pooled effect size for muscle growth: 0.01.

Here is what that number means. If two identical twins trained for twelve weeks — same genetics, same program, same gym, same meals — and one took the pill while the other did not, a DXA scan, an MRI, an ultrasound, and a tape measure would all return the same verdict: no detectable difference. The gap between them falls below the resolution of every measurement tool the field has.

The confidence range straddles zero. You would get a result this close to nothing ninety percent of the time from chance alone.

And the disagreement between studies — how much eight independent research groups differed from each other — was zero. Not low. Not small. Zero. Every team that tested this, across different countries, pill types, and training protocols, found the same nothing.

Strength showed a similar pattern — a small measured difference that did not clear the bar for statistical proof. If anything, the numbers leaned slightly toward pill users — the opposite direction of the fear. The researchers tested nine different ways of analyzing the data. All nine landed in the same place.

If that were the whole article, it would be a useful answer and a forgettable page. What makes this worth staying for is where the fear came from, who kept it alive after the evidence arrived, and what the meta-analysis still cannot tell you.

A Conference Poster From 2009

The single most-cited claim behind the “pill kills gains” fear traces to a conference abstract from 2009. Lee and colleagues presented it at an ACSM meeting. They reported that pill users gained roughly 60% less lean mass than non-users during ten weeks of training.

It was a poster presentation — not a peer-reviewed paper. It had not been through the full publication process. But a number like “60% less muscle” travels fast through Reddit threads, YouTube comments, and gym conversations. By the time most women encountered it, the conference-poster context had been stripped away entirely.

Twelve years later, in 2021, the study was finally published as Reichman and Lee. The data was the same. No new participants, no new analysis. Greg Nuckols — three-time powerlifting world record holder and one of the most trusted voices in evidence-based fitness — reviewed it and concluded: the published paper does not provide net new information beyond the 2009 abstract. [1]

Here is the part that makes the origin story its own punchline. The Reichman & Lee data — the study that launched the Reddit threads, the TikTok clips, the “should I quit my birth control?” anxiety — is already inside Nolan’s meta-analysis. It is one of the eight studies pooled into the 0.01.

The study that started the myth is inside the study that ended it.

The Documented Pipeline

A conference poster does not become a cultural consensus on its own. That requires a distribution system, and researchers have now documented exactly how this one works.

Emily Pfender, a researcher at the University of Pennsylvania, studied what happens when birth control information meets social media at scale. Her team found that 74% of YouTube fitness influencers in their sample encouraged viewers to discontinue hormonal birth control.

On TikTok, roughly half of all posts about birth control promoted discontinuation. Creators cited up to 57 alleged side effects — based overwhelmingly on personal anecdotes, not clinical evidence. One viral TikTok satirizing FDA pill inserts received 2.6 million likes. [2]

The KFF Women’s Health Survey — 3,901 women, nationally representative, conducted in 2024 — measured what that content does to actual behavior. Among women aged 18 to 25, 49% had seen birth control content on social media. And one in seven changed or considered changing their contraception based on what they saw. [3]

The pipeline has an economic layer. The women’s hormonal supplements market was valued at $4.5 billion in 2023, projected to nearly double by 2032. [4] That market grows on fear that creates demand for “natural” alternatives to medications that work.

None of this makes the people who built or followed the content dishonest. Many genuinely believe what they share. But a documented chain exists: a conference poster from 2009, twelve years of gym-floor repetition, TikTok amplification at scale, measurable behavior change, and a market selling the alternative.

Nolan’s 325 women say the foundational claim was never true.

The Question the Meta-Analysis Could Not Answer

The meta-analysis proves the fear is unfounded. But the question beneath the fear — whether your specific pill matters — turns out to have a more interesting answer than expected.

Nolan’s eight studies grouped all oral contraceptive types together. Second-generation pills, third-generation pills, different progestin types — all pooled into one category. The zero-effect finding is real. But it is an average across pill types, and averages can hide opposing signals.

In 2025, Engstad and colleagues tested whether progestin type matters — fifteen women on levonorgestrel, a progestin with testosterone-like properties, trained alongside seventeen naturally cycling women. The levonorgestrel group gained more muscle: 5.5% versus 2.9% in arm lean mass, 10.0% versus 5.3% in mid-thigh muscle size. Both differences large enough to rule out chance. [5]

Before this becomes a new headline: it is one study. Fifteen women. Not randomized — researchers recruited existing pill users, not randomly assigned them. The groups differed in age.

This is an interesting signal from a small trial, not evidence strong enough to change a prescription. The same standard that brought you here — wait for the pooled data — applies to this finding too.

But it suggests the zero in Nolan’s meta-analysis might mask opposing effects. Pills with testosterone-like progestins may support muscle growth. Pills with anti-androgenic progestins may slightly impair it. Pool them together and you get zero — not because nothing happened, but because the effects canceled.

Two other research programs converge from different angles. Phillips and colleagues at McMaster University measured what happens inside the muscle cell during different phases of the pill cycle. Muscle protein synthesis rates were identical. The molecular machinery that builds muscle does not care where you are in your pill pack. [6]

Elliott-Sale’s team pooled 42 studies across 590 women and found the overall effect of oral contraceptives on exercise performance — strength, endurance, power — was at most trivial. Performance was consistent across the pill cycle. [7]

What This Study Mapped and What Remains Unmapped

Here is where an honest page separates from a confident one.

Every included study used oral contraceptive pills. Not a single one tested IUDs, implants, injections, patches, or vaginal rings. If you use a hormonal IUD or an implant, this meta-analysis cannot tell you anything about your method. That gap matters — roughly 11.4% of women aged 15 to 49 use the pill, but millions more use other methods that deliver hormones through different pathways. [8]

The average study lasted 11.6 weeks. Long enough to detect meaningful hypertrophy differences based on prior research, but long-term effects beyond four months remain unmeasured.

Sample sizes were small — an average of 17 women per group per study. Combined, 325 is substantial for this question. But individual variability in training response is enormous, and small groups cannot reliably detect small effects within that range.

Approximately half the included studies used untrained women. Whether the same zero-effect finding holds for elite athletes training at higher loads is an open question.

These are not weaknesses to apologize for. They are the edges of what has been studied versus what has not been studied yet. The article could have quietly said “hormonal contraception does not affect gains” and nobody would have caught the overgeneralization. Specifying that the finding applies to oral contraceptive pills only is the kind of precision that earns trust.

The Variable You Can Cross Off Your List

Nuckols, after reviewing the same body of evidence independently, arrived at the same place: oral contraceptives do not seem to meaningfully impact either strength gains or muscle growth. He also noted that the largest individual study in the pool — Sung and colleagues, tracking 74 women — showed the pill group gaining slightly more strength — +28.02 kg versus +23.30 kg. [1]

When the meta-analysis, the independent expert, and the largest individual study all point the same direction, the variable was never there.

Maybe you considered switching methods because someone in a comments section said their gains improved after quitting. Maybe the doubt lived as background noise in your training sessions — that quiet thought on a heavy set: was that the pill?

The variable drops off your list. Not because someone told you not to worry. Because every study that has ever measured this produced the same result, and that result is indistinguishable from zero.

You can go back to tracking the things that actually move: programming, nutrition, sleep, consistency. The pill was never on the list.

There is a question that usually follows. If the pill does not affect your gains, does your menstrual cycle? That answer lives in a different meta-analysis — and it might be even more surprising.